To view this email as a web page, click here.

The journal psychiatrists read cover-to-cover!

SPECIAL REPORT: Schizophrenia, Part 1

CHAIR: Peter F. Buckley, MD

Read these new articles in this month's print issue!

Immunotherapy for Schizophrenia
Schizophrenia has been associated with immune system abnormalities throughout the lifespan. Could immunotherapy and anti-inflammatory agents be the key to successful treatment?

Balancing the Risks & Benefits of Polypharmacy
At any given time, more than 20% of patients with schizophrenia receive antipsychotic polypharmacy. Here: Special considerations in weighing the risks and benefits.

Related Content From Psychiatric Times

Asthma & Schizophrenia: What's the Link?

Researchers find that asthma in adolescence is associated with schizophrenia spectrum disorder. Read more

Expert Q&A: Schizophrenia and Weight Gain

Dr Leslie Citrome addresses weight gain and metabolic abnormalities in patients with schizophrenia. Read more

Close Up: Adjustment Disorders

One of the most frequently diagnosed psychiatric disorders, adjustment disorders are a common diagnosis in the military, in children and youth, and in the consultation-liaison psychiatric setting. Read more

Up Next Month: Schizophrenia Part 2

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.